XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 113,756 $ 112,501
General and administrative 29,967 33,098
Total operating expenses 143,723 145,599
Loss from operations (143,723) (145,599)
Interest and other income, net 9,486 3,652
Net loss $ (134,237) $ (141,947)
Net loss per share, basic $ (1.77) $ (2.6)
Net loss per share, diluted $ (1.77) $ (2.6)
Weighted-average shares used in computing net loss per share, basic 75,673,081 54,673,572
Weighted-average shares used in computing net loss per share, diluted 75,673,081 54,673,572